Subjects Experiencing at Least One Solicited Systemic Adverse Events (8-Day Follow-Up period After Vaccination, FAS, N = 632).

N = number of subjects in the specified group; n = number of subjects in the specified category (with at least one report of a solicited systemic AE); % = percentages of n based on N; AD = atopic dermatitis; AE = adverse event; Grade ≥ 3 = AE which prevented normal everyday activities or body temperature ≥ 39°C; related AE = AE considered by the investigator to have a possible, probable or definite relationship to study medication.Subjects Experiencing at Least One Solicited Systemic Adverse Events (8-Day Follow-Up period After Vaccination, FAS, N = 632).